The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
ESMO 2023: Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer
Patients with metastatic or recurrent cervical cancer not amenable to curative surgery and/or radiotherapy have…